These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19741129)

  • 1. Statin's excitoprotection is mediated by sAPP and the subsequent attenuation of calpain-induced truncation events, likely via rho-ROCK signaling.
    Ma T; Zhao Y; Kwak YD; Yang Z; Thompson R; Luo Z; Xu H; Liao FF
    J Neurosci; 2009 Sep; 29(36):11226-36. PubMed ID: 19741129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of statin-activated shedding of Alzheimer APP ectodomain by ROCK.
    Pedrini S; Carter TL; Prendergast G; Petanceska S; Ehrlich ME; Gandy S
    PLoS Med; 2005 Jan; 2(1):e18. PubMed ID: 15647781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calpain-2/p35-p25/Cdk5 pathway is involved in the neuronal apoptosis induced by polybrominated diphenyl ether-153.
    Zhang H; Chang L; Zhang H; Nie J; Zhang Z; Yang X; Vuong AM; Wang Z; Chen A; Niu Q
    Toxicol Lett; 2017 Aug; 277():41-53. PubMed ID: 28559121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotoxicity induces cleavage of p35 to p25 by calpain.
    Lee MS; Kwon YT; Li M; Peng J; Friedlander RM; Tsai LH
    Nature; 2000 May; 405(6784):360-4. PubMed ID: 10830966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atorvastatin prevents Aβ oligomer-induced neurotoxicity in cultured rat hippocampal neurons by inhibiting Tau cleavage.
    Sui HJ; Zhang LL; Liu Z; Jin Y
    Acta Pharmacol Sin; 2015 May; 36(5):553-64. PubMed ID: 25891085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium dysregulation induces apoptosis-inducing factor release: cross-talk between PARP-1- and calpain-signaling pathways.
    Vosler PS; Sun D; Wang S; Gao Y; Kintner DB; Signore AP; Cao G; Chen J
    Exp Neurol; 2009 Aug; 218(2):213-20. PubMed ID: 19427306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simvastatin inhibits neural cell apoptosis and promotes locomotor recovery via activation of Wnt/β-catenin signaling pathway after spinal cord injury.
    Gao K; Shen Z; Yuan Y; Han D; Song C; Guo Y; Mei X
    J Neurochem; 2016 Jul; 138(1):139-49. PubMed ID: 26443048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of calpain and p25 of CDK5 pathway in ginsenoside Rb1's attenuation of beta-amyloid peptide25-35-induced tau hyperphosphorylation in cortical neurons.
    Chen X; Huang T; Zhang J; Song J; Chen L; Zhu Y
    Brain Res; 2008 Mar; 1200():99-106. PubMed ID: 18289510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calpain-mediated N-cadherin proteolytic processing in brain injury.
    Jang YN; Jung YS; Lee SH; Moon CH; Kim CH; Baik EJ
    J Neurosci; 2009 May; 29(18):5974-84. PubMed ID: 19420263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Rho-associated kinase in differential regulation by statins of interleukin-1beta- and lipopolysaccharide-mediated nuclear factor kappaB activation and inducible nitric-oxide synthase gene expression in vascular smooth muscle cells.
    Wei CY; Huang KC; Chou YH; Hsieh PF; Lin KH; Lin WW
    Mol Pharmacol; 2006 Mar; 69(3):960-7. PubMed ID: 16317111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential role of TGF-beta/Smad pathway on statin dependent vascular smooth muscle cell regulation.
    Rodríguez-Vita J; Sánchez-Galán E; Santamaría B; Sánchez-López E; Rodrigues-Díez R; Blanco-Colio LM; Egido J; Ortiz A; Ruiz-Ortega M
    PLoS One; 2008; 3(12):e3959. PubMed ID: 19088845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.
    Hisanaga S; Saito T
    Neurosignals; 2003; 12(4-5):221-9. PubMed ID: 14673209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The protective effects of tanshinone IIA on neurotoxicity induced by β-amyloid protein through calpain and the p35/Cdk5 pathway in primary cortical neurons.
    Shi LL; Yang WN; Chen XL; Zhang JS; Yang PB; Hu XD; Han H; Qian YH; Liu Y
    Neurochem Int; 2012 Jul; 61(2):227-35. PubMed ID: 22561406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calpain-mediated truncation of dihydropyrimidinase-like 3 protein (DPYSL3) in response to NMDA and H2O2 toxicity.
    Kowara R; Chen Q; Milliken M; Chakravarthy B
    J Neurochem; 2005 Oct; 95(2):466-74. PubMed ID: 16135096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Processing of cdk5 activator p35 to its truncated form (p25) by calpain in acutely injured neuronal cells.
    Nath R; Davis M; Probert AW; Kupina NC; Ren X; Schielke GP; Wang KK
    Biochem Biophys Res Commun; 2000 Jul; 274(1):16-21. PubMed ID: 10903889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of Rho-Rock signaling pathway protects oligodendrocytes against cytokine toxicity via PPAR-α-dependent mechanism.
    Paintlia AS; Paintlia MK; Singh AK; Singh I
    Glia; 2013 Sep; 61(9):1500-1517. PubMed ID: 23839981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMG-CoA reductase inhibitors decrease angiotensin II-induced vascular fibrosis: role of RhoA/ROCK and MAPK pathways.
    Rupérez M; Rodrigues-Díez R; Blanco-Colio LM; Sánchez-López E; Rodríguez-Vita J; Esteban V; Carvajal G; Plaza JJ; Egido J; Ruiz-Ortega M
    Hypertension; 2007 Aug; 50(2):377-83. PubMed ID: 17592071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PLA(2) signaling is involved in calpain-mediated degradation of synaptic dihydropyrimidinase-like 3 protein in response to NMDA excitotoxicity.
    Kowara R; Moraleja KL; Chakravarthy B
    Neurosci Lett; 2008 Jan; 430(3):197-202. PubMed ID: 18053648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins suppress MMP2 secretion via inactivation of RhoA/ROCK pathway in pulmonary vascular smooth muscles cells.
    Li M; Li Z; Sun X
    Eur J Pharmacol; 2008 Sep; 591(1-3):219-23. PubMed ID: 18619957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the cdk5/p25 fragment formation may explain the antiapoptotic effects of melatonin in an experimental model of Parkinson's disease.
    Alvira D; Tajes M; Verdaguer E; Acuña-Castroviejo D; Folch J; Camins A; Pallas M
    J Pineal Res; 2006 Apr; 40(3):251-8. PubMed ID: 16499562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.